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Physiological Predictors of Weight Regain at 1-Year 
Follow-Up in Weight-Reduced Adults with Obesity
Siren Nymo1,2, Silvia R. Coutinho1, Jens F. Rehfeld3, Helen Truby4, Bård Kulseng1,5, and Catia Martins1,5
Objective: This study aimed to assess whether changes in resting metabolic rate (RMR), exercise-induced 
energy expenditure (EIEE), and appetite following weight loss (WL) are associated with weight regain at 
1 year.
Methods: Thirty-six adults with obesity underwent 8 weeks of a very-low-energy diet, followed by 4 weeks 
of refeeding and a 1-year maintenance program. RMR, EIEE, appetite ratings, and active ghrelin, peptide 
YY, glucagon-like peptide-1, cholecystokinin, and insulin concentrations were measured at baseline, 
week 13, and 1 year.
Results: A 17% WL (−20 ± 5 kg [mean ± SD]; range: −11.7 to −32.2 kg; P < 0.001) was achieved at week 13. 
After 1 year, weight regain was 2.5 ± 9.0 kg (not significant), ranging from −18.2 to 22.5 kg. Both fat mass and 
fat-free mass were reduced at week 13 (−17.9 ± 4.8 and −2.9 ± 2.7 kg, respectively; P < 0.001), while only loss 
of fat mass was sustained at 1 year. WL was associated with reduced RMR, EIEE, and fasting/postprandial 
insulin (all P < 0.001), as well as increased fasting hunger (P < 0.01) and fasting/postprandial active ghrelin 
(P < 0.001). There were no significant correlations between changes in RMR, EIEE, or appetite with WL and 
weight regain at 1 year.
Conclusions: No clear evidence emerged that changes in RMR, EIEE, or appetite following WL can predict 
weight regain at 1 year, but larger studies are needed to confirm these results.
Obesity (2019) 27, 925-931. doi:10.1002/oby.22476
Introduction
The largest challenge in obesity management is not to achieve a clini-
cally relevant weight loss (WL) but to maintain a reduced body weight 
in the long term (1). The majority of adults with obesity experience 
significant weight regain with some relapsing to their original weight 
(1-3). It is well established that diet-induced WL is accompanied by 
several physiological changes on both sides of the energy balance equa-
tion (4,5), with an upregulated appetite (6,7), despite a significantly 
reduced total energy expenditure (TEE) (8). Diet-induced WL was 
shown to reduce TEE because of a decrease in both resting and nonrest-
ing energy expenditure, as a result of reduced body mass and enhanced 
metabolic efficiency (8). Additionally, hunger feelings and the plasma 
concentration of the orexigenic hormone ghrelin increase, whereas 
satiety has been reported to be reduced (5,9). The reduction in resting 
metabolic rate (RMR) seen with WL may be attenuated after a period of 
weight stabilization (8). However, the reduction in TEE (falling below 
predicted values in some individuals, a mechanism known as adaptive 
thermogenesis), as well as the increase in hunger feelings and ghrelin 
secretion, appears to persist in the long term (6,10,11).
It has been repeatedly suggested that the physiological adaptations to WL 
are part of a compensatory response that opposes the reduced-weight state 
and stimulates weight regain (4,5,9,12,13). However, the weight- regain-
promoting actions of the “compensatory mechanisms” are largely specu-
lative because evidence demonstrating a causal relationship between the 
reduced energy expenditure, or increased appetite, seen with WL and 
weight regain is lacking. More studies are needed to elucidate whether the 
changes in appetite and energy expenditure that occur with WL contrib-
ute to weight regain in the long term. Therefore, the aim of this analysis 
was to assess whether changes in RMR, exercise-induced energy expen-
diture (EIEE), subjective appetite feelings, and plasma concentration of 
appetite-related hormones observed with WL are associated with weight 
regain at 1 year in adults who had undergone diet-induced WL.
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Methods
Participants
The study protocol initially included 54 adults with obesity (39 females; 
40 ± 10 years; mean BMI 37 ± 4 kg/m2) recruited from the local com-
munity of Trondheim, Norway, through blogging and advertisements in 
the local newspaper. The protocol used for this study was approved by 
the regional ethical committee (reference number 2012/1901), and the 
study was conducted according to the Declaration of Helsinki. All par-
ticipants signed an informed consent before participation. Participants 
had to be weight stable (< 2-kg change over the previous 3 months), 
not be dieting to lose weight, and with a sedentary lifestyle. Exclusion 
criteria were pregnancy, breastfeeding, clinically significant illness 
(including diabetes), previous WL surgery, and/or taking medication 
known to affect appetite/metabolism or induce WL.
Study design
This was a longitudinal intervention study with repeated measure-
ments. Participants underwent an 8-week supervised very-low- energy 
diet (VLED), followed by a 4-week refeeding phase and a 1-year 
weight-maintenance program. This analysis represents a secondary 
analysis of the main study (14).
Detailed protocol
WL phase. For 8 weeks, participants followed a VLED (Allévo, 
Karo Pharma AS, Stockholm, Sweden) with 550 and 660 kcal/d for 
females and males, respectively (carbohydrates 42%, protein 36%, fat 
18%, and fiber 4%), plus no-energy fluids and low-starch vegetables 
(maximum 100 g/d). For more information regarding this phase, please 
see Nymo et al. (14).
At week 9, participants were gradually reintroduced to normal food 
while withdrawing from the VLED products. An individual diet plan 
was prescribed by a trained dietician and was tailored to individual 
energy requirements (measured RMR × physical activity [PA] level 
[extracted from individual PA monitors used at week 8; SenseWear, 
BodyMedia, Pittsburgh, Pennsylvania]), with 15% to 20% protein, 20% 
to 30% fat, and 50% to 60% carbohydrates, according to the Nordic 
nutritional guidelines (15), aimed at weight stabilization. VLED prod-
ucts were stopped at the end of week 10.
Participants were asked not to change their PA levels during this phase 
of the study. To check for compliance, participants were asked to wear 
armbands (SenseWear) for 7 days at baseline and at weeks 8 and 12 
(week 13). These data were considered valid if the participants wore 
the device for ≥ 4 days, including at least one weekend day, more than 
95% of the time (16).
Weight-maintenance phase. A 1-year follow-up program aimed 
at WL maintenance (WLM) was offered from week 13. The diet plan 
provided at week 13 was revised and tailored to individual needs by 
a trained dietician taking into account individual energy requirements 
(measured RMR × PA level at week 12). The multidisciplinary follow-up 
program included regular individual and group-based sessions, focusing 
on nutritional counseling, PA, and cognitive behavioral therapy.
Measurements
All measurements were conducted after a 12-hour overnight fast. 
Participants were asked not to drink caffeine, to abstain from taking 
any nicotine for 12 hours, and not to perform moderate to vigorous 
PA for 24 hours prior to measurements. Data were collected at base-
line, week 13, and 1 year for both weight and body composition (mea-
sured with air-displacement plethysmography [BOD POD, COSMED, 
Albano Laziale, Italy]) and at baseline and week 13 for other measures.
RMR. RMR was measured by indirect calorimetry (Vmax Encore 
29N; Care Fusion, Baesweiler, Germany) using a canopy system and 
standard operating procedures (17).
EIEE. EIEE was measured by graded cycle ergometry (Monark 
Eromedic 839E; GIH, Vansbro, Sweden) 3 hours after a standardized 
breakfast. Participants pedaled at 60 rpm against graded resistance to 
generate 10, 25, and 50 W of power in sequential 4-minute intervals. 
Gas exchange was measured continuously using a fitted face mask by 
indirect calorimetry (Vmax Encore 29N), and the average of the last 
2 minutes at each stage was used for analysis. Net EIEE was calculated 
by subtracting RMR (kilocalories per minute) from the gross EIEE as 
previously described (18).
Appetite measurements. Subjective appetite feelings (hunger, 
fullness, desire to eat, and prospective food consumption) were 
measured with a 10-cm visual analogue scale (19), and blood samples 
for the analysis of appetite-related hormones (active ghrelin [AG], 
active glucagon-like peptide 1 [GLP-1], total peptide YY [PYY], 
cholecystokinin [CCK], and insulin) were collected in fasting and 
every 30 minutes after a standardized breakfast (600 kcal: 17% protein, 
35% fat, and 48% carbohydrates) for 2.5 hours. Plasma samples 
were analyzed for AG, active GLP-1, total PYY, and insulin using a 
Human Metabolic Hormone Magnetic Bead Panel (LINCOplex Kit; 
Millipore, St. Louis, Missouri) and for CCK using an “in-house” 
radioimmunoassay (RIA) method as previously described (20) (intra- 
and interassay coefficient of variation were < 10% and < 20% for AG, 
active GLP-1, and total PYY; < 10% and < 15% for insulin; and < 5% 
and < 15% for CCK, respectively).
Statistical analysis
Statistical analysis was performed with SPSS Statistics version 
23 (IBM Corp., Armonk, New York), and data are presented as 
mean ± SD. Statistical significance was set at P < 0.05 for changes 
over time in energy expenditure and appetite variables. For correla-
tion and regression analysis, a more conservative significance value 
of P < 0.01 was used to account for the large number of tests per-
formed and to reduce the likelihood of false positives. Area under 
the curve (AUC) for fullness feelings and secretion of appetite- 
related hormones was calculated with the trapezoid rule from 0 to 
150 minutes after the standardized breakfast. Changes in appetite 
and energy expenditure variables with WL (baseline to week 13) 
were assessed by paired t tests or nonparametric alternatives for 
non-normal distributed data. Correlation analysis between weight 
regain (calculated as percent change in body weight between week 
13 and 1 year) and percent changes in energy expenditure and appe-
tite variables as a result of WL (baseline to week 13) were performed 
by Pearson or Spearman correlation for normal and non-normal 
distributed variables, respectively. In addition, linear regression 
assessed the potential predictive factors concerning weight regain, 
using weight regain (percentage) as outcome variable and percent 
changes in energy expenditure and appetite variables with WL as 
potential predictors. The results are presented as regression coef-
ficients (β), with a 95% confidence interval (CI) and P value for 
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linear regressions of weight regain on each predictor separately, 
after adjusting for age, sex, and magnitude of WL (baseline to week 
13 [kilograms]). All analyses are for completers only, as defined by 
participants with data at baseline, week 13, and 1 year.
Results
Of the 54 participants who started the study, 48 provided data at 
week 13 (2 withdrew due to family-related illness, 2 did not tolerate 
the VLCD, 1 was excluded because of consumption of extra foods, 
and 1 was lost to follow-up). A total of 36 (26 males) provided data 
at the 1-year follow-up (1 withdrew for personal reasons, 2 withdrew 
because of their own or family-related illness, 2 withdrew because of 
work constraints making it difficult to return for measurements, and 
7 were lost to follow-up). No differences in baseline characteristics were 
found between those who completed and those who withdrew from the 
study. Changes in body weight and body composition are shown in 
Table 1. A 17.1% ± 2.9% WL (−20.0 ± 5.0 kg; P < 0.001) was measured 
at week 13, with no significant weight regain between week 13 and 
1 year at the group level (2.5 ± 9.0 kg; P = 0.112); however, there was sub-
stantial individual variability (range: −18.2 to 22.5 kg). At 1-year fol-
low-up, 30 out of the 36 participants had WL of at least 10% of baseline 
weight. Fat mass was significantly reduced at week 13 (−17.9 ± 4.8 kg; 
−10.3% ± 4.6%; P < 0.001 for both), with no significant change  between 
week 13 and 1 year. Fat-free mass (kilograms) decreased  between 
baseline and week 13 (−2.9 ± 2.7 kg; P < 0.001) and increased between 
week 13 and 1 year (1.1 ± 2.0 kg; P < 0.01). Fat-free mass (percentage) 
was significantly increased at week 13 (10.3% ± 4.6%; P < 0.001), with 
no significant change between week 13 and 1 year.
Changes in energy expenditure and appetite variables with WL are 
reported in Table 2. WL was accompanied by a significant reduction 
in RMR and EIEE at 10 and 50 W (all P < 0.001) but not at 25 W. An 
TABLE 1 Body weight and composition at baseline and changes over time
Baseline
∆ Baseline to 
week 13 Range of ∆ P value
∆ Week 13 
to 1 year Range of ∆ P value
Weight (kg) 116.80 ± 19.95 −20.00 ± 5.00 (−11.70 to −32.20) < 0.001 2.49 ± 9.02 (−18.20 to 22.5) 0.112
Weight (%) −17.1 ± 2.93 (−9.22 to −22.9) < 0.001 2.33 ± 8.93 (−21.66 to 21.11) 0.126
BMI (kg/m2) 36.63 ± 4.33 −6.25 ± 1.28 (−3.46 to −9.61) < 0.001 0.67 ± 2.73 (−6.33 to 6.29) 0.150
FM (kg) 48.39 ± 12.81 −17.9 ± 4.80 (−12.23 to −34.14) < 0.001 2.33 ± 7.59 (−16.9 to 17.84) 0.083
FM (%) 41.69 ± 6.90 −10.27 ± 4.62 (−5.20 to −27.10) < 0.001 1.11 ± 4.96 (−9.50 to 10.6) 0.195
FFM (kg) 67.08 ± 11.55 −2.91 ± 2.66 (2.83 to −7.99) < 0.001 1.06 ± 1.98 (−3.24 to 5.65) < 0.01
FFM (%) 58.30 ± 6.90 10.30 ± 4.60 (5.20 to 27.10) < 0.001 1.13 ± 4.97 (−9.50 to 10.6) 0.188
Results presented as mean ± SD. N = 36 for all time points. Range: minimum and maximum values.
FM, fat mass; FFM, fat-free mass.
TABLE 2 Changes in energy expenditure and appetite variables from baseline to week 13 and from week 13 to 1 year
Baseline Δ Baseline to week 13 P value Δ Week 13 to 1 year P value
RMR (kcal/d) 1,730 ± 323 −146 ± 169 < 0.001 76 ± 181 0.016
RMR/FFM (kcal/d × kg) 25.63 ± 2.90 −1.11 ± 2.58 0.015 0.72 ± 2.68 0.121
Net EIEE 10 W (kcal/min) 2.78 ± 0.66 −0.60 ± 0.51 < 0.001 0.12 ± 0.40 0.103
Net EIEE 25 W (kcal/min) 3.46 ± 0.69 −0.14 ± 2.59 0.764 −0.25 ± 2.42 0.545
Net EIEE 50 W (kcal/min) 4.74 ± 0.78 −0.55 ± 0.70 < 0.001 0.11 ± 0.55 0.266
Fasting hunger (cm) 3.64 ± 2.02 1.39 ± 2.28 < 0.010 −0.49 ± 3.0 0.327
Fasting DTE (cm) 4.59 ± 1.98 0.57 ± 2.07 0.109 −0.72 ± 2.83 0.134
Fasting PFC (cm) 6.09 ± 2.35 −0.32 ± 2.55 0.457 −0.55 ± 2.31 0.164
AUC fullness (cm/min) 865.83 ± 258.4 74.58 ± 279.32 0.118 7.52 ± 230.00 0.845
Fasting AG (pg/mL) 85.61 ± 45.60 58.55 ± 55.48 < 0.001 −14.11 ± 49.79 0.113
Fasting insulin (pg/mL) 1,175 ± 587 −674 ± 568 < 0.001 26 ± 268 0.582
AUC AG (pg/mL × min) 8,539 ± 4,828 6,103 ± 6,231 < 0.001 −1,006 ± 4,808 0.245
AUC active GLP-1 (pg/mL × min) 1,181 ± 614 −32 ± 773 0.812 168 ± 6,948 0.182
AUC total PYY (pg/mL × min) 9,877 ± 5,445 −476 ± 4,251 0.581 −2,602 ± 5,429 0.028
AUC CCK (pmol/L × min) 3,359 ± 1,319 −29 ± 103 0.111 74 ± 134 0.003
AUC insulin (pg/mL × min) 581,771 ± 222,606 −266,895 ± 196,496 < 0.001 −12,732 ± 133,874 0.600
Results presented as mean ± SD. N = 36 at all time points. “Net”: after subtracting RMR/min. Bold font indicates statistically significant findings.
AG, active ghrelin; AUC, area under the curve; CCK, cholecystokinin; DTE, desire to eat; EIEE, exercise-induced energy expenditure; GLP-1, glucagon-like peptide-1; PFC, 
prospective food consumption; PYY, peptide YY; RMR, resting metabolic rate; FFM, fat-free mass.
Obesity
928    Obesity | VOLUME 27 | NUMBER 6 | JUNE 2019 www.obesityjournal.org
Physiological Predictors of Weight Regain Nymo et al.
increase in hunger ratings in fasting (P < 0.01) and fasting and postpran-
dial AG concentrations, as well as a reduction in fasting and postpran-
dial insulin (all P < 0.001), was also seen with WL.
No significant correlations were found between changes in RMR, 
EIEE, or appetite with WL and WLM at 1 year (Figures 1 and 2). 
However, there was a tendency for a negative association between the 
Figure 1 Association between diet-induced changes (%) in (A) hunger feelings in 
fasting, (B) fasting AG plasma concentration, (C) AG AUC, and (D) CCK AUC and 
percent weight regain at 1-year follow-up (n = 34). AG, active ghrelin; AUC, area 
under the curve; CCK, cholecystokinin.
Figure 2 Association between diet-induced changes (%) in (A) RMR (kcal/kg FFM/d) 
and (B-D) EIEE and percent weight regain at 1-year follow-up (n = 34). EIEE, exercise-
induced energy expenditure; FFM, fat-free mass; RMR, resting metabolic rate.
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dietary-induced changes in CCK AUC and fasting and AUC for AG and 
WLM at 1 year. More specifically, there was a tendency for a reduction 
in CCK AUC with WL to be associated with poorer WLM at 1-year 
follow-up (r = −0.404; P = 0.022) and for increased AG plasma con-
centrations with WL both in fasting and after a meal to be associated 
with improved WLM at 1 year (r = −0.328, P = 0.058 and r = −0.332; 
P = 0.055, respectively). After adjusting for age (β = −0.019; P = 0.913), 
sex (β = −4.313; P = 0.222), and magnitude of WL (kilograms) at week 13 
(β = −0.240; P = 0.683), no significant predictors of weight regain were 
found. However, there was a tendency for percent changes in fasting 
AG and CCK AUC with WL to be associated with weight regain at 
1 year (P = 0.046 and P = 0.031, respectively) (Table 3). No significant 
correlations were observed between energy expenditure (RMR and 
EIEE) or appetite variables at baseline and weight regain at 1-year 
 follow-up (data not shown).
Discussion
The prevention of weight regain is the most clinically relevant chal-
lenge after diet-induced WL, and therefore, it needs to be better 
 understood if we are to succeed in tackling obesity at an individual 
level. The novel findings of this study suggest that the physiological 
adaptations to WL, both at the level of energy expenditure (changes 
in RMR and EIEE) and appetite (changes in hunger and ghrelin), are 
not significant predictors of weight regain at 1-year follow-up. These 
findings contradict the globally accepted “compensatory mechanism 
theory,” which proposes that the reduction in energy expenditure and 
increase in drive to eat seen with WL are drivers of weight regain in 
the long term (4,5,9,12,13).
The data that are available are conflicting regarding whether the initial 
fall in RMR with WL is predictive of weight regain. Wang et al. found 
lower RMR after WL not to be predictive of greater weight regain at 
12-month follow-up in women who underwent an initial 20-week hypo-
caloric diet with or without exercise (21). Pasman et al., on the other 
hand, reported that the amount of weight regained at 14-month fol-
low-up in premenopausal women with obesity was larger in those who 
experienced the greatest decrease in RMR in response to a 2-month 
low-energy diet (22).
Currently, we lack information on whether there is an association 
between a decrease in EIEE, in response to a standardized volume of 
exercise, and WL and weight regain. In 2008, Wang et al. reported the 
magnitude of weight regain during follow-up of weight-reduced women 
to be associated with decreased PA energy expenditure, measured with 
an activity monitor (21).
Sumithran et al. showed in their landmark paper that the upregulated 
appetite hormones and peptides associated with diet-induced WL were 
sustained at 1-year follow-up and claimed that these stimulated weight 
regain and therefore needed to be counteracted if weight regain is to 
be prevented (6). However, they reported no significant correlations 
between the increase in appetite (either subjective appetite feelings 
or plasma concentration of AG, CCK, total PYY, active GLP-1, and 
insulin) seen with WL and weight regain at 1-year follow-up in their 
Supporting Information (6). We recently reported that, in adults with 
15% sustained WL at 1-year follow-up, the drive to eat (subjective 
hunger feelings and ghrelin plasma concentrations) were increased, but 
postprandial fullness feelings were also increased (11). In their system-
atic review, Strohacker et al. reported that the increase in ghrelin and 
reduction in insulin and plasma concentrations seen with WL were not 
predictive of weight regain in free-living humans (23).
Our finding showing a tendency for a larger increase in ghrelin to be 
associated with greater weight regain at 1 year (after adjusting for age, 
sex, and magnitude of WL) was unexpected, but some support for this 
finding was published by Crujeiras et al. in 2010, who showed a signif-
icant negative association between ghrelin changes and WL and weight 
regain 6 months later (24). In fact, they reported that a fall in ghrelin 
after the 8-week hypocaloric diet was related to an increased risk for 
weight regain (odds ratio = 3.109; P = 0.008). These authors proposed 
that these unique findings may be due to central or peripheral resistance 
to this hormone and/or with a putative proinflammatory state (24). 
However, an alternative explanation for the positive association between 
ghrelin and weight regain is that it may reflect a normalization toward 
what is seen in individuals with lower body weight rather than being 
part of an overall “compensatory” response. Indeed, individuals with 
obesity present with lower fasting ghrelin concentrations (25,26), as 
well as reduced postprandial release of satiety peptides, such as GLP-1 
and PYY, compared with healthy-weight controls (25). A lower weight 
regain at 1 year would mean that BMI would be nearer to a “healthy 
weight” and theoretically should be associated with a more normal-
ized ghrelin profile. Our findings would support this, because the less 
weight regained, the lower the BMI was at 1 year (r = 0.5; P = 0.002). 
Unfortunately, studies comparing the plasma concentration of appetite- 
related hormones between reduced-weight individuals with obesity and 
normal-weight individuals have been scarce. Verdich et al. showed that 
WL in individuals with obesity led to a partial normalization of the 
postprandial release of GLP-1, with concentrations rising with WL to 
a level between that of lean individuals and those with obesity (27). 
More research is clearly needed in this area to ascertain whether this 
new hypothesis is valid and to explore further using body composition 
measures rather than relying on body weight alone.
TABLE 3 Potential predictors of weight-loss maintenance at 
1-year follow-up
β 95% CI P
∆RMR 0.096 −0.301 to 0.494 0.625
∆Net EIEE 10 W −0.049 −0.205 to 0.108 0.529
∆Net EIEE 25 W −0.013 −0.153 to 0.127 0.852
∆Net EIEE 50 W 0.088 −0.104 to 0.281 0.356
∆Fasting hunger −0.007 −0.035 to 0.021 0.620
∆AUC fullness −0.061 −0.150 to 0.029 0.178
∆Fasting AG −0.061 −0.121 to −0.001 0.046
∆Fasting insulin −0.042 −0.207 to 0.123 0.607
∆AUC AG −0.045 −0.094 to 0.003 0.064
∆AUC insulin 0.150 −0.053 to −0.262 0.183
∆AUC PYY −0.052 −0.144 to 0.040 0.249
∆AUC GLP-1 −0.009 −0.063 to 0.044 0.727
∆AUC CCK −0.120 −0.229 to −0.012 0.031
Results given as regression coefficients (β), with 95% CI and P value for linear regres-
sions of weight-loss maintenance at 1 year on each predictor separately, after adjust-
ing for age, sex, and magnitude of weight loss (week 13 − baseline [kg]). ∆ = Percentage 
change with weight loss (week 13 − baseline). Bold font indicates statistically signifi-
cant findings.
AG, active ghrelin; AUC, area under the curve; CCK, cholecystokinin; EIEE, exercise-
induced energy expenditure; GLP-1, glucagon like peptide-1; PYY, peptide YY; RMR, 
resting metabolic rate.
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The impact of WL on fullness feelings and the release of satiety hor-
mones remains highly controversial, and outcomes for satiety peptides 
seem to be largely dependent on the hormonal fractions measured. 
Studies measuring total GLP-1 and PYY3-36, fractions that better reflect 
the physiological actions of these hormones on appetite (28,29), have 
reported an increase in the postprandial release of these peptides with 
WL (7,27). This is in contrast with studies that have measured active 
GLP-1, in which no change with WL was found (6,11), and those mea-
suring total PYY, in which either no change (11) or a reduction (6) was 
reported. This again adds evidence to our new hypothesis by showing 
that WL would lead to a normalization of the secretion of GLP-1 and 
PYY, two satiety hormones, toward what is seen in those with a lower 
healthier body weight, in this case by increasing their secretion, which 
is well known to be blunted in individuals with obesity (25,27). In line 
with this, postprandial fullness has been reported not to change (6) or to 
increase in response to diet-induced WL (11).
Eating behavior is extremely complex, and energy intake in free- 
living conditions is likely to be determined by an interplay between 
environmental factors, such as food availability and sensory stimuli, 
and physiological cues (30,31). It is generally accepted that physiology 
can be easily overridden by the environmental cues (32). Therefore, 
even though we found a tendency for a reduction in CCK AUC with WL 
to be associated with more weight regain at 1-year follow-up, there was 
also a tendency for a larger increase in ghrelin, an orexigenic hormone, 
to be associated with less weight regain at 1 year. Moreover, and more 
importantly, dietary-induced changes in subjective feelings of appetite 
were not predictors of weight regain.
Therefore, the challenge of weight regain after diet-induced WL 
remains to be fully understood. It may be that other, still unexplored 
factors may be involved, such as changes in gut microbiota following 
WL, which could favor energy harvesting. At least two studies have 
shown that diet-induced WL leads to an increase of bacterial taxa 
that are important butyrate producers, such as Faecalibacterium and 
Butyricicoccus (33,34). This suggests that diet-induced WL, and indeed 
the type of dietary pattern utilized, may lead to adaptations at the level 
of gut microbiota toward more energy-efficient species, favoring a pos-
itive energy balance.
Despite the fact that, in the present study, all of the measurements were 
performed using robust and validated methods, there are some limita-
tions. The multiplex assay used for the measurements of appetite hor-
mones (except for CCK) is likely to result in less accurate and precise 
measurements compared with optimized assays for each individual hor-
mone. In addition, potential changes in central sensitivity to appetite- 
related hormones were not taken into consideration. Finally, because it 
is a secondary analysis of data, it is likely underpowered to examine the 
relatively large number of predictors associated with weight regain that 
were deemed necessary to explore. More studies, with larger sample 
sizes, are needed to confirm these findings.
The lack of significant changes in postprandial fullness feelings 
reported here are likely to be due to lack of power, as we recently 
published (with a sample of n = 71) a significant increase in postpran-
dial fullness ratings after a 16% WL, which was sustained at 1-year 
follow-up (11). Therefore, the increased feelings of hunger in fasting, 
and the increased fullness feelings after a meal, observed with WL 
may potentially reflect a more accurate and normalized appetite con-
trol system. If we take these findings into account, that the increase 
in hunger feelings seen with WL is sustained in the long term (6,11), 
weight-reduced individuals should get support from their health pro-
fessional on how to cope with this response in order to optimize their 
food choices aiming at an energy-restricted diet, in line with their 
reduced energy needs. Results from this study do have important 
practical implications. Even though participants with obesity should 
expect a significant reduction in both RMR and EIEE after WL and, 
despite that, an increase in the drive to eat, those adaptations are not 
predictive of weight regain in the long term. This likely reflects the 
complexity of body weight regulation (35,36). Overall, if weight- 
reduced individuals want to succeed in the long term, they need to 
adjust to their newer lower-energy needs by sustaining a reduced 
energy intake and, ideally, also increasing their PA levels. PA has 
the potential to not only increase TEE but also improve the sensitiv-
ity of the appetite control system (37,38). Overall, our findings are 
good news if translated into practice appropriately, and weight regain 
should not be seen as an inevitable outcome. Christensen et al., for 
example, showed recently that it is possible to maintain a 10% WL 
over a 3-year period if measures are taken to keep a reduced energy 
intake over time (39).
Conclusion
The physiological adaptations that occur with WL, both at the level of 
energy expenditure and appetite, do not seem to predict weight regain 
in the long term. However, more studies, with larger sample sizes, are 
needed to confirm these findings. O
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